SMi conference speech on targeting the tumor microenvironment
Copenhagen, Denmark – June 1, 2017: Professor Mads Hald Andersen, CSO of IO Biotech and Director of CCIT (Center for Cancer Immune Therapy) at University of Copenhagen Herlev Hospital in Denmark has been invited to speak on day 2 at the SMi conference in London, Sept 2017.
Title of the talk is "Targeting the tumor microenvironment with vaccine-activated anti-regulatory T cells". Mads will describe the discovery and provide examples of antigen-specific anti-Tregs that specifically target immune-suppressive cells, including cancer cells.
The 6th annual Cancer Vaccines 2017 conference aims to discuss key developments in the immuno oncology sphere with particular focus on autologous tumour cell immunotherapy, combinatorial approaches including immune checkpoint inhibitors and IDO inhibitors and clinical trials.